Cairo – Mubasher: The financial statements of Ibnsina Pharma reported a 28.9% year-on-year profit growth during the first nine months of 2019.
Net profits soared to EGP 245.6 million during the January-September period from EGP 190.6 million in the same period of 2018, the company said in a statement to the Egyptian Exchange (EGX) on Monday.
Meanwhile, the company achieved EGP 12.2 billion in sales during the nine-month period ended 30 September, up from EGP 9.68 billion in the year-ago period.
It is worth mentioning that during the first half of 2019, Ibnsina Pharma logged a net profit of EGP 103.19 million, compared to EGP 76.56 million in corresponding period a year earlier.
